Record Revenue and Growth
In Q3, Pennant Group reported revenues of $229 million, an increase of $48.4 million or 26.8% compared to the previous year. Adjusted EBITDA increased by $2.2 million or 14.5%, and adjusted EPS rose by $0.04 or 15.4%.
Successful Acquisition of UnitedHealth Amedisys
Closed on the UnitedHealth Amedisys transaction, adding operations in the Southeast which are expected to deliver long-term growth potential.
Strong Performance in Home Health and Hospice Segment
Segment revenue increased by $37.9 million or 27.9%, while segment adjusted EBITDA rose by $5 million or 22.7% year-over-year.
Senior Living Segment Growth
Revenue in the Senior Living segment grew by 23.2% over the prior year quarter, with same-store occupancy reaching a new high of 81.8%.
Increased Annual Guidance
Raised full year revenue guidance to $911.4 million to $948.6 million and adjusted EPS to $1.14 to $1.18, a 23.4% increase over 2024 EPS.